Latest News and Press Releases

ALLSCHWIL/BASEL, Switzerland, Feb. 24, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) today announced its financial results for the full year 2004. With total net revenue of CHF 471.9 million (FY 2003:...

ALLSCHWIL, Switzerland, Feb. 18 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) (Other OTC:ALIOF) today announced that the Japanese Health Authority (MHLW) have informed the company that the upcoming...

ALLSCHWIL, Switzerland, Feb. 1, 2005 (PRIMEZONE) -- Actelion Ltd (Other OTC:ALIOF) (SWX:ATLN) announced today the publication of the scientific paper evaluating disease outcome of patients with...

ALLSCHWIL, Switzerland, Dec. 22, 2004 (PRIMEZONE) -- Actelion Ltd (Other OTC:ALIOF) (SWX:ATLN) announced today it has initiated the comprehensive global Phase IIb/III development program for...

ALLSCHWIL, Switzerland, Dec. 21, 2004 (PRIMEZONE) -- Actelion Ltd (Other OTC:ALIOF) (SWX:ATLN) announced today that the pivotal study evaluating safety and efficacy of miglustat (Zavesca(R)) in...

ALLSCHWIL, Switzerland, Dec. 20, 2004 (PRIMEZONE) -- Actelion Ltd (Other OTC:ALIOF) (SWX:ATLN) announced today the publication of the full results of the successful study with Tracleer(r) (bosentan)...

ALLSCHWIL, Switzerland, Nov. 6, 2004 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) (Pink Sheets:ALIOF) today announced that the VERITAS study evaluating efficacy and safety of tezosentan in Acute Heart...

ALLSCHWIL, Switzerland, Oct. 26, 2004 (PRIMEZONE) -- Actelion Ltd. (SWX:ATLN) today announced its financial result for the first nine months of 2004. With total net revenues for the first nine months...

ALLSCHWIL, Swtzerland and SAN ANTONIO, Texas, Oct. 18, 2004 (PRIMEZONE) -- Actelion Ltd. (PinkSheets:ALIOF): Studies reported at the American College of Rheumatology (ACR) support early diagnostic...

ALLSCHWIL/BASEL, Switzerland, July 27, 2004 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) today announced its financial results for the first six months of 2004. With total net revenues for H1 2004 of CHF...